Patents Assigned to Pulmosim Therapeutics LLC
  • Publication number: 20230404995
    Abstract: The present disclosure relates generally to compositions and methods for preventing, ameliorating or treating pulmonary fibrosis and/or reducing the severity of one or more risk factors, signs, or symptoms associated with pulmonary fibrosis.
    Type: Application
    Filed: November 17, 2021
    Publication date: December 21, 2023
    Applicant: Pulmosim Therapeutics LLC
    Inventor: Vivek GUPTA